Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Yakugaku Zasshi ; 140(7): 869-875, 2020.
Artigo em Japonês | MEDLINE | ID: mdl-32612048

RESUMO

In recent years, home medical care has been strongly promoted. As a consequence, the conditions managed in home medical care have become increasingly diverse. Heart failure is one of the most common disorders after malignant diseases. Patients with chronic heart failure (CHF) are often forced into hospitalization because of the inability to control symptoms with oral medications, even though they hope to stay at home. Recently, we have experienced a case where the patient required continuous administration of dobutamine at home. In order to carry out CHF care at home successfully, it is necessary to adjust the doses of catecholamine and furosemide swiftly in response to changes in patients' conditions. In this case, the patient was able to spend four months at home thanks to the cooperation of a team of a physician, nurses, and pharmacists. Catecholamine-dependent patients with terminal CHF require expensive medical infusion pumps for precise administration. However, the economic assistance to such patients remains insufficient. Furthermore, dobutamine and furosemide injections are not dispensed extramurally, and therefore might become an impediment to the cooperation of the team. In this symposium, I consider and discuss the role of pharmacists in a home medical care team for patients with terminal CHF.


Assuntos
Insuficiência Cardíaca/tratamento farmacológico , Serviços de Assistência Domiciliar , Equipe de Assistência ao Paciente , Farmacêuticos , Papel Profissional , Catecolaminas/administração & dosagem , Doença Crônica , Dobutamina/administração & dosagem , Furosemida/administração & dosagem , Humanos , Injeções
2.
Mol Nutr Food Res ; 58(8): 1601-9, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24737747

RESUMO

SCOPE: The effects of vitamin E on vitamin K metabolism were elucidated by comparing the effect of tocopherol intake on vitamin K concentrations in rats fed phylloquinone (PK) or menaquinone (MK)-4. METHODS AND RESULTS: Initially, the dietary effect of RRR-α-tocopherol, but not RRR-γ-tocopherol, in decreasing extrahepatic PK concentrations was confirmed. Subsequently, rats were fed a PK or MK-4-containing diet (0.75 mg/kg) with RRR-α-tocopherol (0, 10, 50, or 500 mg/kg) for 6 weeks. In rats fed PK, α-tocopherol consumption decreased PK in kidney, lung, heart, muscle, testis, and brain but not in serum and liver. However, in rats fed MK-4, α-tocopherol consumption did not decrease MK-4 in serum and tissues. Finally, vitamin K- and E-depleted rats were administered PK or MK-4 (0.2 mg) with RRR-α-tocopherol (0, 1, or 10 mg) by gavage. After PK administration, α-tocopherol was observed to decrease PK in kidney, adrenal gland, lung, testis, and brain but not in serum and liver, whereas, after MK-4 administration, α-tocopherol did not affect MK-4 in serum and tissues. CONCLUSION: Excess α-tocopherol decreased extrahepatic PK in rats fed PK but not MK-4 in rats fed MK-4.


Assuntos
Regulação para Baixo , Vitamina K 1/antagonistas & inibidores , Deficiência de Vitamina K/induzido quimicamente , alfa-Tocoferol/intoxicação , Animais , Suplementos Nutricionais , Masculino , Especificidade de Órgãos , Ratos Wistar , Organismos Livres de Patógenos Específicos , Deficiência de Vitamina E/sangue , Deficiência de Vitamina E/induzido quimicamente , Deficiência de Vitamina E/dietoterapia , Deficiência de Vitamina E/metabolismo , Vitamina K 1/administração & dosagem , Vitamina K 1/metabolismo , Vitamina K 1/uso terapêutico , Vitamina K 2/administração & dosagem , Vitamina K 2/análogos & derivados , Vitamina K 2/sangue , Vitamina K 2/metabolismo , Vitamina K 2/uso terapêutico , Deficiência de Vitamina K/sangue , Deficiência de Vitamina K/dietoterapia , Deficiência de Vitamina K/metabolismo , alfa-Tocoferol/administração & dosagem , alfa-Tocoferol/antagonistas & inibidores , alfa-Tocoferol/metabolismo , gama-Tocoferol/administração & dosagem , gama-Tocoferol/metabolismo
3.
Lipids ; 48(7): 687-95, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23700248

RESUMO

From an enzyme kinetic study using rat liver microsomes, α-tocopherol has been suggested to accelerate the other vitamin E catabolism by stimulating vitamin E ω-hydroxylation, the late limiting reaction of the vitamin E catabolic pathway. To test the effect of α-tocopherol on catabolism of the other vitamin E isoforms in vivo, we determined whether α-tocopherol accelerates depletion of γ-tocopherol and tocotrienol and excretion of their metabolites in rats. Male Wistar rats were fed a γ-tocopherol-rich diet for 6 weeks followed by a γ-tocopherol-free diet with or without α-tocopherol for 7 days. Intake of γ-tocopherol-free diets lowered γ-tocopherol concentrations in serum, liver, adrenal gland, small intestine, and heart, but there was no effect of dietary α-tocopherol on γ-tocopherol concentrations. The level of urinary excretion of γ-tocopherol metabolite was not affected by dietary α-tocopherol. Next, the effect of α-tocopherol on tocotrienol depletion was examined using rats fed a tocotrienol-rich diet for 6 weeks. Subsequent intake of a tocotrienol-free diet with or without α-tocopherol for 7 days depleted concentrations of α- and γ-tocotrienol in serum and tissues, which was accompanied by a decrease in the excretion of γ-tocotrienol metabolite. However, neither the tocotrienol concentration nor γ-tocotrienol metabolite excretion was affected by dietary α-tocopherol. These data showed that dietary α-tocopherol did not accelerate the depletion of γ-tocopherol and tocotrienol and their metabolite excretions, suggesting that the positive effect of α-tocopherol on vitamin E ω-hydroxylase is not sufficient to affect the other isoform concentrations in tissues.


Assuntos
Tocotrienóis/sangue , Tocotrienóis/urina , alfa-Tocoferol/sangue , alfa-Tocoferol/urina , gama-Tocoferol/sangue , gama-Tocoferol/urina , Administração Oral , Glândulas Suprarrenais/metabolismo , Animais , Citocromo P-450 CYP4A/metabolismo , Fígado/metabolismo , Masculino , Miocárdio/metabolismo , Ratos , Ratos Wistar , Tocotrienóis/administração & dosagem , alfa-Tocoferol/administração & dosagem , gama-Tocoferol/administração & dosagem
4.
J Nutr ; 143(7): 1067-73, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-23700348

RESUMO

We have shown that intake of sesame seed and its lignan increases vitamin E concentrations and decreases urinary excretion levels of vitamin E metabolites in male Wistar rats, suggesting inhibition of vitamin E catabolism by sesame lignan. The aim of this study was to examine whether dietary sesame seed also increased vitamin K concentrations, because its metabolic pathway is similar to that of vitamin E. To test the effect of sesame lignan on vitamin K concentrations, male Wistar rats were fed a control diet or a diet with 0.2% sesamin (a sesame lignan) for 7 d in experiment 1. Liver phylloquinone (PK), menaquinone-4 (MK-4), and γ-tocopherol were greater in rats fed sesamin than in control rats. To test the effect of sesame seed on vitamin K concentrations, male Wistar rats were fed a control diet or a diet with 1, 5, or 10% sesame seed for 3 d in experiment 2. Liver and kidney PK and γ-tocopherol but not MK-4 were greater in rats fed sesame seed than in control rats, although differences in dietary amounts of sesame seed did not affect the PK concentrations. For further confirmation of the effect of sesame seed, male Wistar rats were fed a control diet or a diet with 20% sesame seed for 40 d in experiment 3. Kidney, heart, lung, testis, and brain PK and brain MK-4 were greater in rats fed sesame seed than in control rats. The present study revealed for the first time, to our knowledge, that dietary sesame seed and sesame lignan increase not only vitamin E but also vitamin K concentrations in rat tissues.


Assuntos
Dieta , Dioxóis/administração & dosagem , Lignanas/administração & dosagem , Sesamum/química , Vitamina K 1/análise , gama-Tocoferol/análise , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Dioxóis/química , Coração/efeitos dos fármacos , Rim/efeitos dos fármacos , Rim/metabolismo , Lignanas/química , Fígado/efeitos dos fármacos , Fígado/metabolismo , Pulmão/efeitos dos fármacos , Pulmão/metabolismo , Masculino , Ratos , Ratos Wistar , Sementes/química , Testículo/efeitos dos fármacos , Testículo/metabolismo , Vitamina K 1/metabolismo , Vitamina K 2/análogos & derivados , Vitamina K 2/análise , Vitamina K 2/metabolismo , gama-Tocoferol/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA